SREBP-1c is an essential mediator of the lipogenic response to insulin and carbohydrate intake, and its upregulation is often observed in metabolic disorders characterized by hyperinsulinemia, such as obesity and type 2 diabetes [10,11,12]. Here, INS is linked to Other metabolic disease.